Biotech | August 02, 2021
Windlas Biotech opens for subscription this week
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
Sun Pharma has committed Rs. 100 crores towards these initiatives
Aurobindo has one of the most enduring generics ecosystems among peers
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
India sales grew 23.5% YoY with consolidation of Wockhardt products
The agreement will help ensure wider reach and access to patients in India
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
Subscribe To Our Newsletter & Stay Updated
